Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible

Authors :: M.E.M. van der Noordaa
R. Voorthuis
M.J. Vrancken Peeters
C. Loo
J. Van Urk
E.J.T. Rutgers
I. Ioan
Vincent O. Dezentjé
E. van Werkhoven
F. van Duijnhoven
Emma J. Groen
T. Wiersma
Source :: European Journal of Cancer. 92:S82-S83
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Breast cancer
business.industry
Internal medicine
medicine
In patient
medicine.disease
business
Systemic therapy

Tools